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To determine whether exhaled breath contains Torque teno virus (TTV) or not,  we tested exhaled 
breath condensate (EBC) samples by semi-nested PCR assay.  We detected TTV DNA in 35ｵ (7/20) of 
EBC samples collected from the mouth of one of the authors,  demonstrating that TTV DNA is 
excreted in exhaled breath with moderate frequency.  TTV DNA was detected also in oral EBC sam-
ples from 4 of 6 other authors,  indicating that TTV DNA excretion in exhaled breath is not an excep-
tion but rather a common phenomenon.  Furthermore,  the same assay could amplify TTV DNA from 
room air condensate (RAC) samples collected at distances of 20 and 40cm from a human face with 40 
(8/20) and 35ｵ (7/20) positive rates,  respectively.  TTV transmission has been reported to occur dur-
ing infancy.  These distances seem equivalent to that between an infant and its household members 
while caring for the infant.  Taken together,  it seems that exhaled breath is one of the possible trans-
mission routes of TTV.  We also detected TTV DNA in 25ｵ (10/40) of RAC samples collected at a 
distance of more than 180cm from any human face,  suggesting the risk of airborne infection with 
TTV in a room.
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orque teno virus (TTV) is one of human anellovi-
ruses that have small non-enveloped virions 
containing single-stranded,  circular DNA genomes 
[1].  The more sensitive polymerase chain reaction 
(PCR) assays that have been recently developed have 
demonstrated that 70 to 100ｵ of the general popula-
tion throughout the world is chronically infected with 
TTV except in the United Kingdom [2].
　 Although TTV has not yet been etiologically linked 
to known diseases,  TTV infection has been associated 
with accelerated disease development,  poorer clinical 
outcome,  higher morbidity and/or increased mortality 
in many diseases [1].  For example,  subjects with 
periodontitis had a signiﬁcantly higher TTV DNA load 
in the gingival tissue than those without disease [3].  
TTV DNA prevalence and loads in both nasal swabs 
and plasma were signiﬁcantly higher in patients with 
bronchopneumonia than in those with milder disease 
[4].  Serum prevalence of TTV DNA was signiﬁ-
cantly higher in patients with severe idiopathic inﬂam-
matory myopathies than in those with milder disease 
[5].
　 Because there is neither an eﬀective antiviral 
therapy nor a vaccine available for TTV at the pres-
ent time,  the only way to reduce the prevalence of 
TTV and thereby counteract TTV-associated diseases 
T
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is to block TTV transmission from infected to unin-
fected individuals.  Recently,  Naganuma et al.  [6] 
studied saliva samples from healthy children and 
detected TTV DNA in 6,  34 and 90ｵ of children 
aged 1,  4 and 42 months,  respectively.  From this 
data they concluded that TTV acquisition during the 
prenatal or neonatal period seemed infrequent and that 
TTV prevalence increased with age and apparently 
reached a plateau at or before 42 months of age.  
Thus,  we must prevent TTV transmission to children 
less than 42 months old.
　 TTV DNA has been detected in various body ﬂuids 
including semen [7,  8],  cervical ﬂuid [9,  10],  nasal 
and throat secretions [4,  11],  bile juice [12],  breast 
milk [13,  14] and saliva [14-16].  The body ﬂuids of 
parents and/or other household members have been 
regarded as possible sources of TTV infection of their 
children.  If TTV is transmitted only via the body 
ﬂuids,  we can block TTV transmission to uninfected 
children by protecting children from contact with 
TTV-positive body ﬂuids.  However,  exhaled breath 
of the TTV-infected adults may be contaminated with 
the virus since it passes through their nose,  mouth and 
throat,  which are moistened by TTV-positive body 
ﬂuids.  If so,  it would only be natural that the children 
could be infected by TTV in the breath exhaled from 
TTV-positive adults.  In this case,  we need to make 
other plans to cope with TTV-contaminated exhaled 
breath in addition to protecting children from contact 
with TTV-positive body ﬂuids.  However,  there is no 
information regarding contamination of exhaled breath 
with TTV.
　 The aim of this study was to determine whether 
exhaled breath had potential risk as a vehicle of TTV 
transmission.  In order to check for the existence of 
TTV in exhaled breath,  we collected exhaled breath 
condensate (EBC) samples from the 7 authors by 
chilling exhaled air and examined the condensates for 
the presence of TTV.  Laboratory diagnosis of TTV 
infection has been dependent on PCR detection of viral 
DNA due to lack of other appropriate assays.  
Unequivocal culture systems and well-characterized 
animal models are not available for the virus isolation.  
There are no easy-to-use immunological methods to 
detect anti-TTV antibody and TTV antigens.  Southern 
blot hybridization is not sensitive enough to detect 
TTV DNA in samples such as body ﬂuids and serum.  
In the present study,  TTV presence in EBC samples 
was tested by semi-nested PCR assay.  As a result,  we 
demonstrated that TTV DNA was detectable in 
numerous EBC samples of 5 of the 7 authors.
Materials and Methods
　 Sample collection. We collected 20 samples of 
oral and nasal EBC and saliva from author A and 5 
samples of oral EBC and saliva from each of authors 
B,  C,  D,  E,  F and G.  These seven authors included 
4 males and 3 females.  Their mean age (± standard 
deviation) was 33.0 (±13.0) years old and the age 
range was 21-53 years old.  They were not suﬀering 
from any illness during the sampling period.  Also,  we 
collected 20 samples of room air condensate (RAC) 
for each collection condition.  Informed consent with 
appropriate documentation was obtained from our-
selves.  The EBC and saliva samples were collected 
after gentle tooth brushing and mouth rinsing with 
water.  During the EBC collection,  we kept normal 
tidal breathing by nasal inhalation and oral or nasal 
exhalation without coughing,  sneezing or speaking.  
Oral and nasal EBC and RAC samples were collected 
using 3 diﬀerent hand-made collection devices (Fig.  
1).
　 Oral EBC samples were collected in the device 
shown in the panel A of Fig.  1.  The device was com-
posed of a mouthpiece,  a 10-ml pipette,  a one-way 
bulb and 2 bellows-tubes.  The 2 bellows-tubes were 
connected by a one-way bulb.  The mouthpiece was 
attached to one end of the connected bellows-tubes and 
the pipette was linked to another end.  The bellows-
tube adjacent to the pipette was rotated to prevent 
samples from contamination with saliva droplets.  All 
components of the device were made of plastic and the 
device was used only one time.  Exhaled air was sent 
into the device via the mouthpiece,  passed through 
the 2 bellows-tubes and one-way bulb and was chilled 
in the pipette by 2 refrigerants.  The refrigerants were 
pre-cooled at －80℃.  The ﬂuid that was accumulated 
in the device for approximately 30min was poured into 
a 20-ml plastic container and assayed as an oral EBC 
sample.
　 Nasal EBC samples were collected by the same 
method as oral EBC samples except for the collection 
device (panel B of Fig.  1).  The nasal EBC collection 
device had a nosepiece and a straight bellows-tube 
instead of the mouthpiece and rotated bellows-tube of 
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the oral EBC collection device.  We inhaled nasally 
through a hole in the top side of the nosepiece and sent 
exhaled air into the device by closing the hole with a 
gloved ﬁnger.
　 RAC samples were collected by an open system 
using the device shown in panel C of Fig.  1.  This 
device was made of a plastic tray (16×24×2cm),  
the inner surface of which was covered with a brand-
new polyvinylidene chloride ﬁlm.  We breathed out 
through the mouth and at a distance of 20,  40,  80,  
160 or more than 160cm from the RAC collection 
device.  An RAC sample was accumulated on the sur-
face of the ﬁlm for approximately 30min by chilling 
the opposite side of the tray with refrigerant and was 
collected into a 20-ml plastic container by a micropi-
pette with a ﬁltered tip.  The refrigerants were pre-
cooled at －80℃.  The device was set at the same 
height as a human face and the collection side of the 
device fronted on the face when we collected RAC 
samples at sites that were a speciﬁc distance (20 to 
160cm) from a human face.  Alternatively,  when col-
lecting at sites far from any face,  the device was 
placed at a height of 180cm from the room ﬂoor,  and 
the collection side faced the room wall.
　 Saliva samples were collected by accumulating 
saliva quietly in the oral cavity for approximately 
10min and by drooling it into a 20ml plastic container.
　 Sample pretreatment. There has been no 
report about materials which are constantly contained 
in EBC and can be used as internal standards.  For 
example,  the β-actin gene which has been used as an 
internal control in many PCR experiments could not 
be detected in 42ｵ of EBC samples [17].  Also,  other 
materials such as a total DNA,  which have been used 
to standardize the amount of template DNA in PCR 
assays,  do not seem to be contained in EBC at the 
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Fig. 1　 Schematic illustration of EBC and RAC collection devices.  (A) Oral EBC collection device.  Nasally inhaled air was exhaled into 
the device through a mouthpiece held in a mouth,  passed through a straight bellows-tube,  a one-way bulb and a rotated bellows-tube that 
prevented passage of saliva droplets.  The breathed air that passed through the rotated bellows-tube was chilled in a pipette by pre-cooled 
refrigerants at －80℃.  The condensate that accumulated within both the pipette and the latter half of the rotated bellows-tube (the gray 
area) was poured into a 20-ml plastic container and assayed as described in Materials and Method.  (B) Nasal EBC collection device.  
Nasally inhaled air was exhaled into the device trough a nosepiece inserted into nostrils,  ﬂowed through 2 straight bellows-tubes and a 
one-way bulb between the tubes.  Then,  nasal EBC was trapped in the gray area,  collected and assayed in the same way as the oral 
EBC.  (C) RAC collection device.  Room air was cooled on the surface of a brand-new sheet of polyvinylidene chloride ﬁlm covering a 
polystyrene tray by the use of refrigerant on the opposite side of the tray.  The refrigerant was pre-cooled at －80℃.  RAC accumulated on 
the ﬁlm (the gray area) was collected by a micropipette with a ﬁltered tip and assayed by the same methods as oral and nasal EBCs.  RAC 
was collected at distances of 20,  40,  80,  160 or more than 160cm from a human face.
same concentration.  In order to make it possible to 
detect TTV DNA under the same condition without 
using internal standards,  we did not extract nucleic 
acids from the samples and ampliﬁed TTV DNA from 
exactly the same volume of sample solution.  This assay 
concept avoided the laborious use of an external stan-
dard to determine the extraction eﬃciency and also 
was expected to reduce the risk of contamination of the 
samples with exogenous target DNA.
　 To put the assay concept into practice,  we pre-
treated the samples as follows: We froze each sample 
at －80℃ immediately after collection and concen-
trated it by a Freeze dryer ALPHA 1-2 (Martin 
Christ Gefriertrocknungsanlagen Gm bH,  Osterode 
am Harz,  Germany).  After being thawed,  the concen-
trated sample was supplemented with 10mM Tris•Cl 
(pH8.0),  1mM EDTA•2NA (pH8.0),  0.5ｵ SDS and 
0.2mg/ml proteinase K and its volume adjusted to 
one-tenth of that before the sample was concentrated 
with DNase,  RNase-free distilled water.  Subsequently,  
the sample was incubated at 53℃ for 3h to digest 
proteins,  further incubated at 95℃ for 10min to 
inactivate the enzyme and then stored at －80℃ until 
analysis by semi-nested PCR.  For saliva,  each sample 
was supplemented with 10mM Tris•Cl (pH8.0),  1mM 
EDTA•2NA (pH8.0),  0.5ｵ SDS and 0.2mg/ml pro-
teinase K right after collection and treated in the same 
way as EBC and RAC samples.
　 In addition to the samples for the semi-nested PCR 
assay,  EBC,  RAC and saliva samples were stored at 
－80℃ for α-amylase assay without any pretreat-
ment.
　 Detection of TTV DNA using semi-nested 
PCR. We detected TTV DNA in EBC,  RAC and 
saliva samples by the in-house semi-nested PCR assay.  
The primers for detection of TTV DNA were designed 
based on already-reported TTV genome sequences.  A 
conserved region of the TTV genome was selected by 
aligning the genome sequences of 20 TTV strains 
(GenBank accession number AB008394,  AB025946,  
AB028668,  AB028669,  AB038619,  AB038620,  
AB064604,  AB064605,  AB064606,  AB064607,  
AF351132,  AF435014,  AJ620233,  AJ620234,  
AJ620235,  AM712032,  AM712033,  AM712034,  
AY666122 and NC002076),  and 3 primers corre-
sponding to the region were synthesized.  The forward 
and reverse primers of the outer pair were 
5ʼ-attttgctacgtcactaaccacg-3ʼ (TF5m) and 5ʼ-cccgaatt-
gccccttgac-3ʼ (TR6),  respectively.  The forward and 
reverse primers of the inner pair were TF5m and 
5ʼ-taaactcacctccggcac-3ʼ (TR1c),  respectively.  TF5m,  
TR6 and TR1c are located at nucleotide positions 
1-23,  204-221 and 177-194 in the TTV genome 
(AB008394),  respectively.  The predicted length of the 
amplicons produced by the inner primers is 194bp.
　 The ﬁrst PCR was performed in a 20-µl reaction 
mixture containing 1×Taq DNA polymerase reaction 
buﬀer (Roche Diagnostics K.K.,  Tokyo,  Japan),  
200µM of each deoxynucleotide triphosphate (Roche 
Diagnostics K.K.),  0.5 U of Taq DNA polymerase 
(Roche Diagnostics K.K.),  0.1µM of forward and 
reverse primers,  10ｵ Tween 20 and 10µl of each 
pretreated sample.  In the cases of EBC and RAC,  
10µl of the pretreated sample contained template 
DNA quantitatively equivalent to that in 100µl of 
each sample before pretreatment.  In the case of 
saliva,  the amount of template DNA in a 10-µl pre-
treated sample was equal to that in 9.18µl of each 
untreated sample.  The following ampliﬁcation program 
was used for the ﬁrst PCR mixture: 7min at 94℃;  
35 cycles of 30 sec at 94℃,  45 sec at 59℃ and 30 
sec at 72℃; and a ﬁnal extension of 5min at 72℃.  
Conditions for the second PCR mixture were the same 
as those for the ﬁrst one except that forward and 
reverse primers were contained at a ﬁnal concentra-
tion of 1µM in place of 0.1µM; also,  1µl of the ﬁrst 
PCR product was added instead of 10µl of pretreated 
sample and Tween 20 was not included in the mixture.  
Cycling conditions for the second PCR were the same 
as the ﬁrst one except for the annealing at 63℃ 
instead of 59℃ and the cycling number of 25 times.  
After ampliﬁcation was completed,  aliquots of the 
semi-nested PCR products were separated by electro-
phoresis (3ｵ agarose gels) and photographed under 
UV light after ethidium bromide staining.  The mini-
mum detection limit of our semi-nested PCR was 
determined using 10-fold serial dilutions of the cloned 
TTV DNA fragment.  It was estimated that 10 copies 
of the fragment or more were detectable per reaction.
　 Negative controls for the PCR procedure were 
made by adding water instead of sample solution,  and 
no TTV DNA ampliﬁcation occurred after the second 
PCRs.  Positive controls for the PCR procedure were 
prepared by adding water including 100 copies of the 
cloned TTV DNA fragment in place of the sample 
solution,  and we achieved the target DNA ampliﬁca-
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tion after the second PCRs in all cases.  The fragment 
was cloned from the amplicon of the ﬁrst PCR.  The 
sequence identities between the fragment and each of 
the above-described 20 TTV strains ranged from 76.8 
to 94.1ｵ.  In addition to controls for the PCR proce-
dure,  we collected 20 samples of outdoor air conden-
sate as negative controls for sample collection and 
pretreatment.  The outdoor air condensate samples 
were collected on an emergency stairway of 5th ﬂoor 
of a building in the device used for collection of oral 
EBC except that air was brought into the device by an 
electric suction pomp.  The samples were pretreated 
and examined in the same way as described above,  and 
all of the samples turned out to be negative for TTV 
DNA.  The data of these controls are not shown in the 
ﬁgures of this report.
　 Assay of α-amylase activity. Activities of α
-amylase in EBC,  RAC and saliva samples were 
measured enzymatically with Salivary α-Amylase 
Assay Kit (Salmetrics LLC,  PA,  USA).  Frozen 
samples that were not pretreated were thawed,  and 
8µl of each sample was assayed according to the 
manufacturerʼs instruction.
　 Statistical analysis. The statistical signiﬁ-
cance between sets of data was evaluated by the 
Pearsonʼs chi square test with p＜0.05 being signiﬁ-
cant.  The relationship between sets of data was evalu-
ated by calculating Pearsonʼs product-moment correla-
tion coeﬃcient (r).
Results
　 Activity of α-amylase in oral and nasal EBC 
samples. From one of the present authors (author 
A),  we gathered saliva samples by drooling and col-
lected oral and nasal EBC samples in the devices 
shown in panels A and B of Fig.  1.  Then,  we exam-
ined the samples for activity of α-amylase,  a well-
known enzyme that is secreted in saliva (Panels A,  B 
and C of Fig.  2).  Detection of α-amylase activity in a 
sample would serve as evidence that the sample con-
tained saliva.  While there were α-amylase activities 
ranging from 107 to 505U/ml in saliva samples,  the 
activity of the enzyme was lower than the lowest 
detection limit (0.0164U/ml) in all of the oral and 
nasal EBC samples.  Thus,  the oral and nasal EBC 
samples seem not to have been contaminated with 
saliva.
　 Detection of TTV DNA in exhaled breath.
Next,  we tested the samples for the presence of TTV 
DNA by semi-nested PCR assay.  The assay ampliﬁed 
TTV DNA from 85ｵ (17/20) of saliva samples 
(Panels A and D of Fig.  3),  suggesting that author A 
was surely positive for the virus and the EBC samples 
from the author were worth being assayed for the 
virus.  Then,  we assessed the EBC samples for the 
presence of TTV DNA.  We detected TTV DNA in 
35ｵ (7/20) of oral EBC samples and in 10ｵ (2/20) 
of nasal EBC samples (Panels B,  C and D of Fig.  3).  
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Fig. 2　 Activities of α-amylase in saliva (A),  oral EBC (B),  
nasal EBC (C) and RAC (D) samples.  All saliva and EBC samples 
were collected from author A as described in the Materials and 
Methods.  RAC samples were collected at a distance of 20cm from 
the face of author A.  The lowest detection limit of the activity was 
0.0164U/ml.
The results indicate that exhaled breath from the 
author A undoubtedly contained TTV DNA,  although 
the TTV DNA-positive rates in the oral and nasal 
EBC samples were signiﬁcantly lower than that of the 
saliva samples.
　 Generality of TTV excretion in exhaled 
breath. To determine whether or not author Aʼs 
exhalation of TTV DNA was an exception,  we exam-
ined six other authors (authors B,  C,  D,  E,  F and G) 
using semi-nested PCR.  With regard to saliva,  we 
detected TTV DNA in 90ｵ (27/30) of the samples 
and found that all of the 6 authors were positive for 
TTV (Panels A and C of Fig.  4).  As the result of 
examining oral EBC samples from these TTV-positive 
authors,  we could detect TTV DNA in 20ｵ (6/30) of 
the samples and in 4 of the 6 authors (Panels B and C 
of Fig.  4).  Therefore,  it seems that excretion of TTV 
in exhaled breath is not an exceptional case but is 
common.
　 Detection of TTV DNA in room air near a 
human face. Although the above-described TTV 
DNA-positive data demonstrated TTV DNA excretion 
in exhaled breath,  the data were obtained by closed 
systems using devices in which the exhaled breath was 
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Fig. 3　 Detection of TTV DNA in exhaled air.  Electrophoretic proﬁles of the semi-nested PCR products ampliﬁed from saliva,  oral EBC 
and nasal EBC samples are shown in panels A,  B and C,  respectively.  We collected all samples from author A and assayed them as 
described in Materials and Methods.  Signals observed at a position of approximately 200bp were positive signs for TTV DNA.  The abbre-
viation M means a lane of molecular markers.  (D) TTV DNA-positive rates in saliva,  oral EBC and nasal EBC samples.  Columns represent 
the TTV DNA-positive rates calculated from the results in the panels A,  B and C.  A single asterisk means that the value is signiﬁcantly 
lower than that in saliva samples (p＜0.05).
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Fig. 4　 Generality of TTV DNA detection in exhaled breath.  Electrophoretic proﬁles of the semi-nested PCR products ampliﬁed from 
saliva and oral EBC samples are shown in panels A and B,  respectively.  We collected and assayed saliva and oral EBC samples in the 
same way as in Fig.  3 except for the authors from whom the samples were collected.  Samples 1 to 5,  6 to 10,  11 to 15,  16 to 20,  21 to 
25 and 26 to 30 were collected from authors B,  C,  D,  E,  F and G,  respectively.  Signals observed at a position of approximately 200bp 
are positive signs for TTV DNA.  The abbreviation M means a lane of molecular markers.  (C) TTV DNA-positive rates in saliva and oral 
EBC samples.  Columns represent the TTV DNA-positive rates calculated from the results in panels A and B.  A single asterisk means that 
the value is signiﬁcantly lower than that in the saliva samples (p＜0.05).
not diﬀused (Panels A and B of Fig.  1).  In actual 
circumstances,  there is no tube that connects an 
excretor of TTV directly to a recipient.  Thus,  it was 
necessary to verify whether or not the room air near 
a human face contains TTV.  We collected RAC sam-
ples at distances of 20,  40,  80 and 160cm from the 
face of author A using the device shown in panel C of 
Fig.  1.  We quantiﬁed α-amylase activity in 20 RAC 
samples collected at a distance of 20cm from the face 
but could not detect any activity of the enzyme in the 
samples (Panel D of Fig.  2),  suggesting that the RAC 
samples were not contaminated with saliva.  Then,  we 
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Fig. 5　 Detection of TTV DNA in room air near a human face.  Electrophoretic proﬁles of the semi-nested PCR products ampliﬁed from 
RAC samples obtained at distances of 20,  40,  80 and 160cm from the face of the author A are shown in panels A,  B,  C and D,  respec-
tively.  We collected and assayed RAC samples as described in Materials and Methods at the same height as the face of the author A.  
Signals observed at a position of approximately 200bp are positive signs for TTV DNA.  The abbreviation M means a lane of molecular 
markers.  (E) TTV DNA-positive rates in RAC samples obtained at distances of 20,  40,  80 and 160cm from the face.  Columns represent 
the TTV DNA-positive rates calculated from the results in panels A,  B,  C and D.  A single asterisk means that the value is signiﬁcantly 
higher than those of RAC samples at distances of 80 and 160cm from the face,  and a double asterisk means that the value is signiﬁcantly 
higher than that in RAC samples at a distance 160cm from the face (p＜0.05).
screened the RAC samples for presence of TTV DNA 
by the same methods as described above (Fig.  5).
　 As a result,  we found that TTV DNA was detect-
able in RAC samples collected at distances of 20 and 
40cm from a human face with positive rates of 40 
(8/20) and 35ｵ (7/20),  respectively.  These TTV 
DNA-positive rates were comparable to that in oral 
EBC samples from the same author.  Thus,  it seems 
that room air near a human face contains an equivalent 
amount of TTV to orally exhaled breath,  and that 
exhaled breath may be one of the possible transmis-
sion routes of TTV in an actual situation.  We 
detected TTV DNA also in RAC samples collected at 
distances of 80 and 160cm from the face.  There was 
a negative correlation between the TTV DNA-positive 
rates and the distances from the face (r＝－0.90).  
The correlation seems to indicate the natural diﬀusion 
of TTV in room air.
　 Detection of TTV DNA in room air far from 
a human face. We could detect TTV DNA in 
RAC samples that were collected not only at sites 
near a human face (20 and 40cm) but also at a site far 
from the face (160cm).  This result may suggest that 
TTV can drift in room air for a long distance.  To 
better understand the distribution of TTV in room air,  
we collected RAC samples at 2 diﬀerent room sites 
located at a height more than 180cm from a room ﬂoor 
and at a distance more than 160cm from any human 
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Fig. 6　 Detection of TTV DNA in room air far from a human face.  Electrophoretic proﬁles of the semi-nested PCR products ampliﬁed 
from RAC samples obtained at the dead end and entrance of the room are shown in panels A and B,  respectively.  We collected RAC 
samples in the same way as in Fig.  5 except that the samples were collected at a height of 180cm from the room ﬂoor and at distances of 
more than 160cm from any human face and assayed in the same way as Fig.  3.  Signals observed at a position of approximately 200bp 
are positive signs for TTV DNA.  The abbreviation M means a lane of molecular markers.  (C) TTV DNA-positive rates in RAC samples 
obtained at the dead end and entrance of the room.  Columns represent the TTV DNA-positive rates calculated from the results in panels 
A and B.  The single asterisk means that the value is signiﬁcantly higher than that in RAC samples collected at the entrance of the room 
(p＜0.05).
face.  The collection side of the device used to accu-
mulate RAC did not face any human in the room but 
faced a room wall.  We examined the RAC samples for 
the presence of TTV DNA by the semi-nested PCR 
assay,  resulting in ampliﬁcation of TTV DNA from 
the samples with a much higher frequency than we had 
anticipated (Fig.  6).  TTV DNA was detected in 40ｵ 
(8/20) of the samples that were collected at the dead 
end of the room and in 10ｵ (2/20) of the samples that 
were collected at the entrance of the room.  The result 
suggests a wide distribution of TTV in room air.  The 
diﬀerence in the TTV DNA-positive rate between the 
dead end and entrance of the room was statistically 
signiﬁcant,  suggesting that the virus may accumulate 
in the inner part of the room.
Discussion
　 First,  we demonstrated TTV DNA in both oral and 
nasal EBC samples from author A.  The mean TTV 
DNA-positive rate in oral EBC samples reached 35ｵ,  
indicating that the presence of TTV DNA is not rare 
in exhaled air.  Second,  we detected TTV DNA in oral 
EBC samples not only from author A but also from 4 
of 6 other authors examined in the following investi-
gation,  suggesting that excretion of TTV in orally 
exhaled air is not unique to author A but is a common 
phenomenon.  Third,  we detected TTV DNA also in 
RAC samples collected at distances of 20 and 40cm 
from a human face with positive rates of 40 and 35ｵ,  
respectively.  These TTV DNA-positive rates are 
comparable to that of oral EBC samples.  Thus,  it 
seems that exhaled air contains TTV in actual situa-
tions.  TTV transmission occurs during infancy [6] 
and it has been assumed that saliva droplets from 
household members of an infant are the sources of 
TTV transmission to the infant.  The above-described 
results suggest that exhaled air from household mem-
bers may be a possible source of TTV transmission to 
the infant in addition to saliva droplets.
　 Although α-amylase activity was more than 107U/
ml in saliva,  the activity of the enzyme in exhaled air 
was below the lowest detection limit (0.0164U/ml).  
Thus,  it seems that our oral EBC samples were not 
contaminated with saliva,  and the TTV DNA-positive 
results obtained in the oral EBC samples were not 
directly due to the contamination of samples with the 
TTV DNA-positive saliva.  Nevertheless,  the TTV 
DNA-positive rate in saliva samples from author A was 
signiﬁcantly higher than those in oral and nasal EBC 
samples collected from him.  Hence,  we can not com-
pletely deny the possibility that TTV in EBC samples 
is associated with the virus secreted in saliva; the 
origin of TTV DNA in the EBC samples is still 
unknown.
　 In addition to directly exhaled breath and room air 
near a human face,  we could detect TTV DNA also in 
room air far from human faces,  suggesting that TTV 
drifts for long distances and is widely distributed in 
room air.  During RAC sample collection at sites far 
from a human face,  the ventilation of the room was not 
so good because the air in the room was ventilated 
only through the entrance door and the door was 
opened for a short time,  when someone entered or 
exited the room.  Since TTV is a non-enveloped virus,  
TTV is considered highly resistant to environmental 
stressors [18].  For example,  TTV infectivity has 
been reported not to be lost even after 95h of dry heat 
treatment [19].  Together with this remarkable sta-
bility of TTV particles,  our result may suggest the 
risk of airborne infection with TTV in rooms without 
good ventilation.
　Breath is exhaled constantly by TTV-infected per-
sons,  and so the generation frequency of exhaled 
breath is much higher than those of other vehicles of 
TTV spread.  TTV acquisition seems to occur during 
infancy in most cases [6].  It is assumed that members 
of a household in which there is an infant may attempt 
to protect the infant from contact with their body ﬂu-
ids but not usually from their exhaled air.  As for the 
risk of TTV transmission,  therefore,  it seems possi-
ble that airborne infection via exhaled air may be 
comparable to infection though other routes.  However,  
at this moment in time,  no one can evaluate the risk of 
airborne infection with TTV quantitatively as we can-
not estimate TTV infection eﬃciencies in humans via 
other vehicles of spread,  largely because there is a 
paucity of experimental systems to determine TTV 
infection eﬃciency.  Infection experiments in humans 
cannot be performed for ethical reasons.  Also,  prac-
tical animal models for the quantitative assay of TTV 
infection are not available.  In addition,  studies of the 
infectivity of TTV are very limited due to lack of cell 
lines that support suﬃcient TTV replication.  These 
diﬃculties should be resolved in order to enable risk 
assessment of TTV transmission routes including 
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airborne infection.
　 Even in oral EBC from the same author,  there 
were both TTV DNA-positive and -negative samples.  
This suggests the possibility that diﬀerences in the 
physical and mental conditions of a host in ordinary 
life may inﬂuence TTV replication and/or TTV 
excretion from the host.  Information on the conditions 
aﬀecting TTV replication and excretion would seem 
useful for preventing transmission of the virus and 
related disease deterioration.
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